Recent News
On April 20, 2026, the company issued first-quarter 2026 results and declared a quarterly dividend; subsequent reporting summarized Q1 net income of $11.4 million, diluted EPS of $1.45, and continued expansion into the Texas market with a new branch. The company also scheduled an earnings release and conference call in early April and filed an 8-K disclosing loan repricing and investment securities details.
Technical Analysis
Directional indicators show a weak trend environment: ADX at 17.47 signals no established trend, even as DI+ stands at 21.45 while decreasing and DI- at 15.60 shows a dip-and-reversal. That combination points to fading upside directional pressure and a recent increase in downside pressure that undercuts near-term bullish conviction.
MACD reads 0.86 with the signal line at 0.88 and a peak-and-reversal pattern; MACD sits below its signal line, indicating momentum has peaked and shifted toward bearish momentum, which increases the likelihood of short-term downside pressure on the stock price.
MRO sits at 28.65 and registered a peak-and-reversal. Because MRO is positive, the price currently sits above a modeled target and carries elevated potential to drift lower; the recent MRO reversal reinforces the momentum-based downside risk implied by MACD.
RSI at 55.08 shows neither overbought nor oversold conditions, but the RSI peak-and-reversal indicates momentum fatigue rather than accumulation; combine that with the MACD and MRO signals and the technical bias tilts toward short-term weakening rather than continuation higher.
Price sits at $63.03, just below the 20-day average of $63.63 and above the 50-day and 200-day averages ($61.10 and $57.20 respectively). The 12-day EMA and the 12-day EMA trend show a peak-and-reversal, implying a short-term pullback within a longer-term base. Bollinger band placement keeps price near the midpoint between the $62.25 lower band and $65.01 upper band, suggesting limited immediate volatility expansion. Ichimoku lines show the Tenkan at $63.17 above the Kijun at $61.60, but price trading slightly below Tenkan weakens that signal for immediate follow-through. Collectively, these price/average relationships support the view of a corrective phase within an otherwise neutral-to-positive longer-term posture.
Fundamental Analysis
Q1 results show diluted EPS of $1.45 versus an estimate of $1.39, an EPS beat of $0.06 or roughly 4.3%. Forward EPS stands at $1.53875 with a forward PE of 38.76. WMDST values the stock as fair-valued, and the reported EPS beat contributes to that assessment by supporting near-term earnings stability.
Profitability and growth metrics present mixed signals: reported earnings growth sits at -0.685% year-to-date, while earnings growth quarter-over-quarter declined by -91.622% and year-over-year at -105.18%; revenue growth registers 0.534% on the headline figure but shows quarter-to-quarter contraction of -74.523% and year-over-year decline of -65.37%. Those QoQ and YoY movements point to episodic volatility in top-line and bottom-line drivers across recent periods and reduce confidence in immediate growth acceleration.
Valuation multiples show the trailing PE at 41.98, below the industry peer mean of 47.39 and above the industry peer median of 32.58. The company’s PEG sits at -61.28 versus an industry peer mean of 2.40 and an industry peer median of -13.36, reflecting the combination of current earnings levels and analyst growth expectations; the negative PEG signals that simple growth-adjusted valuation comparisons require careful interpretation. Forward PE at 38.76 remains below the industry peer mean of 50.69, which supports the fair-valued determination from a forward-multiple perspective.
Other items of note: invested capital shows $-498,901,000; cost of debt reads 19.07%; cash-flow-to-earnings reported at $0.00 for the period. The company disclosed a net unrealized loss on investment securities and provided loan repricing and maturity schedules in recent filings, which matter for interest-rate and liquidity dynamics but do not alter the fair-valued WMDST appraisal at present.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2026-03-31 |
| REPORT DATE: | 2026-04-20 |
| NEXT REPORT DATE: | 2026-07-20 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 1.39 | |
| EPS Actual | $ 1.45 | |
| EPS Difference | $ 0.06 | |
| EPS Surprise | 4.317 % | |
| Forward EPS | $ 1.54 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 41.979 | |
| Price To Earnings QoQ | 5.894 % | |
| Price To Earnings YoY | 26.915 % | |
| Price To Earnings IPRWA | high: 69.149 mean: 47.391 HBCP: 41.979 median: 32.582 low: 28.819 |
|
| PE/G Ratio | -61.284 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 38.761 | |
| Forward PE/G | -56.586 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -498.90 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 19.072 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.534 % | |
| Revenue Growth QoQ | -74.523 % | |
| Revenue Growth YoY | -65.37 % | |
| Revenue Growth IPRWA | high: 14.153 % mean: 7.825 % HBCP: 0.534 % median: -3.072 % low: -10.975 % |
|
| Earnings Growth | -0.685 % | |
| Earnings Growth QoQ | -91.622 % | |
| Earnings Growth YoY | -105.18 % | |
| Earnings Growth IPRWA | high: 45.909 % mean: 15.265 % HBCP: -0.685 % median: -15.369 % low: -50.199 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | — | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |